Home / Recalls / Clinical Specialties Compounding Pharmacy / D-668-2013

D-668-2013 Class II Terminated

Recalled by Clinical Specialties Compounding Pharmacy — Augusta, GA

Recall Details

Product Type
Drugs
Report Date
July 10, 2013
Initiation Date
March 20, 2013
Termination Date
February 22, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4ml

Product Description

Test cyp 25 mg-Estradiol cyp 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

Reason for Recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Distribution Pattern

FL, GA and SC.

Code Information

Lot number CABDBHAB:54, Exp date: 7/16/2013

Other recalls by Clinical Specialties Compounding Pharmacy

  • D-665-2013 Class II — Test Cyp 100 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, (March 20, 2013)
  • D-672-2013 Class II — Test cyp 35 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, A (March 20, 2013)
  • D-679-2013 Class II — Tetracaine(buffered) 0.25% solution, Clinical Specialties Compounding Pharmacy, (March 20, 2013)
  • D-634-2013 Class II — Acetylcysteine 2 % Solution, Clinical Specialties Compounding Pharmacy, 318 Bas (March 20, 2013)
  • D-638-2013 Class II — Diazepam 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Au (March 20, 2013)
  • D-664-2013 Class II — Test Cyp 10 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, A (March 20, 2013)
  • D-674-2013 Class II — Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharmacy, (March 20, 2013)
  • D-641-2013 Class II — Estradiol Valerate 30 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Bast (March 20, 2013)
  • D-646-2013 Class II — Hydroxyprogesterone 250 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Ba (March 20, 2013)
  • D-644-2013 Class II — HCG 2000 units/ml, 30 mL syringe, Clinical Specialties Compounding Pharmacy, 318 (March 20, 2013)